Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hytrin vs Hytrin + Hinechol in benign prostatic hyperplasia with LUTS
KCT0005736Phase 4Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terazosin in benign prostatic hyperplasia (BPH), Micturition disorder, sponsored by Il-Yang Pharmaceutical. Started Jan 2021; status: completed.
02
Drugs
terazosin
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on KCT0005736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005736.